Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Share this article:
Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Sponsor and Collaborators

Stanford University
Millennium Pharmaceuticals, Inc.

Contact
Contact: Richa Rajwanshi
(650) 736-4031
richar@stanford.edu

Principal Investigator
Bruno Carneiro de Medeiros Stanford University

ClinicalTrials.gov Identifier
NCT01162031
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia ...

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation